Thursday, 29 March 2018

The Aussies are working on this too....

http://www.proactiveinvestors.com.au/companies/news/193977/kazia-therapeutics-progresses-phase-ii-clinical-trial-for-brain-cancer-drug-193977.html
Posted by at
Labels:

1 comment:

  1. Stephen W29 March 2018 at 17:53

    Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR
    https://www.ncbi.nlm.nih.gov/pubmed/27096040

    ReplyDelete

Subscribe to: Post Comments (Atom)